Woonsocket, RI, United States
Woonsocket, RI, United States
SEARCH FILTERS
Time filter
Source Type

News Article | May 24, 2017
Site: www.prnewswire.com

Mr. Gledhill manages about 10,000 professionals across Asia and is focused on strengthening the bank's technology and infrastructure platform to drive greater resilience, organizational flexibility and innovation. Executing against DBS' strategy to be at the forefront of digital transformation, he plays a lead role in driving the bank's innovation agenda. Mr. Gledhill's portfolio includes the group's operations, which are focused on re-imagining customer journeys and the way business is supported, so as to make banking simpler and more effortless for customers. He has 25 years of experience in the financial services industry, and prior to joining DBS in 2008, he worked at J.P. Morgan, holding senior regional positions in Technology & Operations. At DBS, he is also the Director of Singapore Clearing House, a member of an IBM Advisory Board and the National Super Computing Centre Steering Committee, and a board advisor to the Singapore Management University School of Information Systems. "Winning the MIT Sloan CIO Leadership Award is a great honor, and is testament to the bank's collective efforts in re-imagining banking for our customers," said Mr. Gledhill. "This has been an all-encompassing journey, whether it is changing the culture and mindsets of our people, re-architecting our technology infrastructure, or leveraging big data, biometrics and AI to make banking simple and seamless for our customers. Winning this award from MIT, an organization that is at the forefront of driving innovation, is a great encouragement to all of us at DBS." Dr. Westerman presented the award to Mr. Gledhill at the pre-Symposium dinner at the Exchange Conference Center in Boston, MA, on the evening of May 23. The three other distinguished Award finalists were Carlo Bozzoli of Enel, Julia Davis of Aflac, and Stephen Gold of CVS Health. About the MIT Sloan CIO Symposium The MIT Sloan CIO Symposium is the premier global conference for CIOs and digital business executives to become more effective leaders. In one day, CIOs and senior IT executives explore enterprise technology innovations and business practices, and receive actionable information that enables them to meet the challenges of today and the future. The Symposium offers a unique learning environment by bringing together the academic thought leadership of MIT with the in-the-trenches experience of leading, global CIOs and industry experts. The MIT Sloan CIO Symposium is organized and developed by the MIT Sloan Boston Alumni Association, the MIT Initiative on the Digital Economy (IDE), and the MIT Sloan Center for Information Systems Research (CISR). For more information, visit www.mitcio.com. Editor's Note: Journalists interested in learning more or speaking with the Award winner and finalists should contact Caroline Legg (caroline@warnerpr.com; 978-255-4488), Warner Communications. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mit-sloan-cio-symposium-announces-winner-of-the-2017-cio-leadership-award-300463286.html


News Article | May 25, 2017
Site: www.prnewswire.com

Entre los patrocinadores de la 35ª Gala Gourmet Anual se encuentran Samsung, patrocinador  presentador; Bentley Motors USA/Volkswagen Group of America y la National Association of Chain Drug Stores Foundation, patrocinadores titulares; Chevron, patrocinador distintivo; Aflac, BGR Group, Inc., BlueCross BlueShield Association, BNSF Railway, CVS Health, Intrexon Corporation, Lockheed Martin Corporation, S&P Global y United Technologies Corporation, patrocinadores regionales; y The Hill, National Journal, The Umbrella Syndicate, y The Washington Diplomat, medios patrocinadores.


News Article | May 26, 2017
Site: www.reuters.com

BOSTON (Reuters) - CVS Health Corp's Omnicare unit has agreed to pay $23 million to resolve a long-running whistleblower lawsuit alleging that it took kickbacks from a drugmaker, according to settlement papers released on Friday.


"A diagnosis of lung cancer shouldn't happen by chance or when the disease is in its later stages, as it does for so many," said Harold Wimmer, National President and CEO of the American Lung Association. "We know that early detection is key – survival rates are five times higher when lung cancer is detected early. This is why awareness of lung cancer and screening options is critical in partnership with research funding to support more treatment options and methods of early detection." The American Lung Association's 3rd annual Women's Lung Health Barometer revealed that, while there have been positive shifts in women's perceptions of lung cancer, awareness remains critically low. Anyone can get lung cancer, and sadly one woman dies every eight minutes in the U.S. from the disease. Early detection and treatment of lung cancer translates to higher survival rates, however only 18 percent of lung cancer cases among women are diagnosed early, when the disease is most treatable. Survivor: Millennials vs. Gen X 2016 victor Adam Klein has joined the LUNG FORCE initiative as a LUNG FORCE Hero after losing his mother to lung cancer just one hour after returning home from the competition. Klein's mother, Susie, lost her life to the disease only nine short months after receiving a stage 4 lung cancer diagnosis. In honor of his mother's legacy, Klein most recently participated in LUNG FORCE's 2nd Annual LUNG FORCE Advocacy Day in Washington, D.C., to advocate for additional research funding. "My mother was an inspirational woman, filled with strength, love and compassion. She bravely faced the disease for nine months, but more importantly, thrived for 60 years," said Klein. "Lung cancer is the number one cancer killer of women and yet only 2 percent of women have lung cancer on their health radar so it's imperative that we make it a priority. Early detection and more effective treatment options will save lives which is why I've committed myself to raising awareness of lung cancer as well as critical funding for research in the fight against this disease." LUNG FORCE Kicks Off Social Campaign #ShowYourLUNGFORCE Without our lungs, we could not sing, dance, run or laugh – we couldn't breathe. LUNG FORCE is celebrating the power of our lungs by demonstrating the many ways we use them every day. To encourage people to take a stand against lung cancer, LUNG FORCE is launching a social campaign called #ShowYourLUNGFORCE, asking Americans to take action and mobilize their social networks to amplify awareness and raise funds to defeat lung cancer. It's easy for everyone to get involved: Donations will support the American Lung Association's investment in lung cancer research and patient support – including early detection, biomarker testing and advocacy for more federal research funding. For the fourth year in a row, LUNG FORCE National Presenting Sponsor CVS Health is rallying support with in-store fundraising. From Sunday, May 7th through Saturday, May 27th, CVS Pharmacy customers can visit any of its 7,900 stores to support LUNG FORCE by making a $1, $3 or larger donation at the register or online at Lung.org/CVS to raise funds for lung cancer awareness, research and education. The in-store fundraising campaign is part of Be The First, a 5-year $50 million initiative funded through CVS Health and the CVS Health Foundation to help deliver the nation's first tobacco-free generation. While anyone can get lung cancer, smoking is the leading risk factor for lung cancer, along with radon gas, air pollution and secondhand smoke exposure. In addition to donating to the campaign, customers can also visit Lung.org/CVS for easy ways to help their communities become tobacco-free, which is key to making a difference against lung cancer. "CVS Health is a proud sponsor of LUNG FORCE and its work to ensure that we fight the number one cancer killer," said Helena Foulkes, President, CVS Pharmacy. "As a company that is committed to helping people on a path to better health, we want to help raise funds and spread awareness of this deadly disease. Together with the American Lung Association's LUNG FORCE, we're working to create tobacco-free communities to help beat lung cancer." For more information about LUNG FORCE including local LUNG FORCE Walks taking place throughout May, visit LUNGFORCE.org. About The American Lung Association The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease, through research, education and advocacy. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to improve the air we breathe; to reduce the burden of lung disease on individuals and their families; and to eliminate tobacco use and tobacco-related diseases. For more information about the American Lung Association, a holder of the Better Business Bureau Wise Giving Guide Seal, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org. About LUNG FORCE LUNG FORCE is a national initiative led by the American Lung Association to unite women against lung cancer, the #1 cancer killer of women. LUNG FORCE has three priorities: 1) Make lung cancer a cause that people care about – and act on; 2) Educate and empower patients and healthcare providers and 3) Raise critical funds for lung cancer research. The American Lung Association's LUNG FORCE is nationally presented by CVS Health. Find out more at LUNGFORCE.org About CVS Health CVS Health is a pharmacy innovation company helping people on their path to better health. Through its nearly 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at CVSHealth.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/american-lung-associations-lung-force-encourages-americans-to-take-action-against-the-no-1-cancer-killer-during-national-womens-lung-health-week-may-7-13-300454084.html


New performance targets introduced in this year's report include expanding the company's commitment to preventing and mitigating prescription drug abuse by increasing pharmacist education and outreach to 750,000 children and families by 2020. In addition, to respond to the health care industry's complex and ever-changing compliance landscape, the company is harnessing new technologies that help colleagues stay informed of and comply with regulations and has committed to providing more than two million hours of annual compliance training to colleagues across the enterprise. "We're incredibly proud of everything we accomplished in 2016 and believe that our business contributions have helped to address critical health care issues and deliver more affordable, accessible and effective care," said Larry Merlo, President and Chief Executive Officer for CVS Health. "Our corporate social responsibility strategy supports our growing business while helping people on their path to better health and making the world a healthier place to live." "Prescription for a Better World is more than the title of our report – it's a comprehensive approach to CSR that engages colleagues across our organization to make measurable progress in fulfilling our purpose," Eileen Howard Boone, SVP of Corporate Social Responsibility and Philanthropy for CVS Health writes in the Report. "As I look ahead to the next ten years, I see so many opportunities for our CSR strategy to play an even bigger role in supporting our business and delivering value to our customers, communities and stakeholders." The Report was developed in accordance with the Global Reporting Initiative (GRI) G4 Guidelines, an international framework that is widely used by organizations to report on their CSR and sustainability performance. For more information on GRI, visit http://www.globalreporting.org/. The Report is available online at http://cvshealth.com/social-responsibility/corporate-social-responsibility. About CVS Health CVS Health is a pharmacy innovation company helping people on their path to better health. Through its nearly 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cvs-health-corporate-social-responsibility-activities-address-important-national-and-local-health-care-issues-and-contribute-to-economic-growth-300454662.html


WOONSOCKET, Rhode Island, 10 de mayo de 2017 /PRNewswire-HISPANIC PR WIRE/ -- CVS Health (NYSE: CVS) divulgó hoy su décimo Reporte de Responsabilidad Social Corporativa (CSR) anual, titulado Receta para un Mundo Mejor, que ofrece actualizaciones sobre el progreso de los objetivos de CSR...


News Article | May 12, 2017
Site: www.prnewswire.com

WOONSOCKET, R.I., May 12, 2017 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced that Larry Merlo, the company's president and chief executive officer, will be speaking to investors at the UBS Global Healthcare Conference on May 24, 2017, at approximately 10:00 a.m. ET. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website for all interested parties, and will be archived and available for a one-year period. To access the webcast or an archive of the event, visit http://investors.cvshealth.com.


In welcoming Schapiro to the corporate board, Chairman David W. Dorman commented on the unique expertise she would bring to CVS Health. "We welcome Mary's extraordinary record of leadership and unmatched commitment to investor protection and sound financial policy," said David W. Dorman, Chairman of the Board, CVS Health. "Her extensive knowledge of the U.S. financial and regulatory landscape and understanding of corporate governance and complex financial infrastructure will be of great value to the board and benefit to CVS Health and its stockholders." Schapiro currently serves as the Vice Chair of Promontory Advisory Board, part of Promontory Financial Group, a leading strategy, risk management and regulatory compliance firm that was acquired by IBM Corporation in November 2016. From January 2009 through December 2012, Ms. Schapiro was Chairman of the U.S. Securities and Exchange Commission, becoming the first woman to serve as that agency's Chairman. During her four years leading the agency which followed the 2008 financial crisis, the SEC pursued one of the busiest rulemaking agendas in its history. Additionally, the agency executed a comprehensive restructuring program to improve protections for investors. Before becoming SEC chairman, Ms. Schapiro served as CEO of the Financial Industry Regulatory Authority, the largest nongovernmental regulator of securities firms. Earlier, she was Commodity Futures Trading Commission (CFTC) chairman and a commissioner of the SEC. She began her career at the CFTC, serving first as a trial attorney and later as counsel and executive assistant to the chairman. In addition to being the first woman to serve as SEC chairman, Ms. Schapiro is the only person to have served as chairman of both the SEC and the CFTC. Ms. Schapiro is also a director of General Electric Company and the London Stock Exchange Group. A graduate of Franklin and Marshall College, she received a JD from George Washington University. About CVS Health CVS Health is a pharmacy innovation company helping people on their path to better health. Through its nearly 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cvs-health-stockholders-elect-former-sec-chairman-mary-l-schapiro-as-new-director-at-annual-meeting-300455224.html


News Article | May 11, 2017
Site: www.prnewswire.com

The one-day tournament on Monday, June 19th will feature 18 of the nation's top golfers, comprised of six PGA TOUR, six LPGA Tour and six PGA TOUR Champions players. Each team will be made up of one player from each respective Tour. The top two scores from each hole per team will be counted towards its final score. The lowest team score at the end of 18 holes will be named the Champions of the 2017 CVS Health Charity Classic. Team pairings will be released on a rolling basis as the event draws closer. The golf professionals participating at the 2017 CVS Health Charity Classic include: In addition to the golf tournament, the CVS Health Charity Classic, which has donated more than $20 million dollars to area non-profits since 1999, will continue its tradition of giving back to the Southern New England community with a series of events, including: "The focus of the CVS Health Charity Classic has always been to give back to our local community," said Eileen Howard Boone, Tournament Chairwoman, CVS Health Charity Classic. "The addition of Crave RI and the inclusion of celebrity athletes provide a great opportunity for the Southern New England region to come together to support the meaningful work being done by non-profits that are providing assistance to those that need it the most." The CVS Health Charity Classic will again be honoring veterans by offering complimentary admission to Rhode Island Country Club for the golf tournament for all active, reserve and retired Military Service Members and their dependents. Veterans can simply present a valid Common Access Card or Retired Military Card at the gate. First responders and their families also receive free admission with a valid ID. Single day tickets for the 2017 CVS Health Charity Classic are now on sale at ticketmaster.com/CharityClassic for $10 each. Children 17 and under are free with a ticketed adult. For additional information on tickets, fans can call 866-CVS-9441 or visit cvshealthcharityclassic.com. About the CVS Health Charity Classic The CVS Health Charity Classic is Rhode Island's largest charitable event series and hosts some of the best PGA TOUR, LPGA Tour and PGA TOUR Champions professionals in the world. Since its inception in 1999, the CVS Health Charity Classic has donated more than $20 million to charities around the region, providing vital funding for a variety of critical programs serving children, families and people in transition throughout Southern New England. For more information, visit To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cvs-health-charity-classic-announces-enhancements-for-2017-event-series-300455966.html


Context: Inappropriate pain documentation is likely to be an important contributor to the poor management of pain in elderly patients in the emergency department (ED). Failure to assess pain limits ability to treat pain. Objectives: The objectives of this study were to examine the relationship between visit characteristics of elderly patients and pain score documentation in the ED, and to determine predictors of analgesic use in the ED. Methods: This was a cross-sectional analysis of documented ED visits by elderly patients from the National Hospital Ambulatory Medical Care Survey (2003-2006). The study included 5661 ED visits by patients aged 65 years and older, representing an estimated 18 million ED visits during the four-year study period. Univariate logistic regression was used to analyze associations among independent variables and documentation of pain. Multivariate logistic regression was used to determine whether nonopioid and opioid analgesic prescribing disparities existed and were associated with pain level. Results: Pain score documentation was found to be suboptimal in the elderly population in this study, with only 75% of visits having documented pain scores. Older age, self-pay, patients residing in the Western region of the United States, and emergent ED visits were associated with decreased pain score documentation. Documentation of pain score was associated with increased odds of an analgesic prescription and opioid analgesic prescription. Odds of prescribing an opioid increased significantly with increasing level of pain severity. Conclusion: ED pain score documentation is suboptimal in the elderly population. Disparity in the use of analgesic prescriptions and opioid analgesics exists and may result in patients not receiving analgesics. Improving pain assessment and documentation, changes in attitude toward analgesic prescribing, and recognition of ethnic, racial, and age differences in patients with pain have the potential to contribute to effective management of pain in the ED. © 2011 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Loading CVS Health collaborators
Loading CVS Health collaborators